The MIA:STEP training introduces empirically supported mentoring products to enhance the MI skills of treatment providers, as well as tools to fortify a supervisorâ€™s ability to provide structured, focused, and effective clinical supervision. MIA:STEP introduces an effective strategy for observation-based clinical supervision, the use of which has the potential to improve counselor skills beyond MI.
The Addiction Severity Index (ASI) is one of the most universally used instruments for the assessment of substance abuse and related problems. This Blending product is designed to address how to transform required paperwork into clinically useful information. Addiction Counselors administer the ASI, yet often fail to use its findings. To assist clinicians, supervisors, and managers with utilizing the ASI results more readily, this product addresses the key tenets of treatment objectives and interventions--Measurable, Attainable, Time-Limited, Realistic, and Specific--referred to as Treatment Planning M.A.T.R.S.
This training is based on the blending product designed to enhance awareness among multidisciplinary addiction professionals about buprenorphine treatment. It is designed to provide a broad overview of the medication, its effects, and the role of non-physician practitioners in providing and supporting the treatment of individuals receiving this medication. This presentation will include additional information regarding Medication Assisted Treatment (MAT) for opioid addiction treatment as well as information based on NIDA's Clinical Trials Network study on Prescription Opioid Addiction Treatment Study (POATS). POATS includes findings regarding implications for the treatment of adults dependent on on prescription opioids and how treatment providers can incorporate study findings and recommendations into their practice.